Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients

Clinical trial NCT05203458 · COMPLETED

Trial details

NCT number: NCT05203458
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer, HER2

Start date: 2022-02-24
Primary completion: 2023-07-05
Enrollment: 3136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.